Establishing a New Standard
Aquablation therapy removes tissue effectively, consistently, and with a low risk of complications – providing the surgeon with predictable and reproducible outcomes and a better quality of life for the patient.
Predictable Precision
The first FDA-cleared surgical robot utilizing automated tissue resection for the treatment of lower urinary tract symptoms due to BPH, offering the peace of mind that comes with consistency and precision.
Predictable Precision
The first FDA-cleared, automated surgical robot for the treatment of lower urinary tract symptoms due to BPH, offering the peace of mind that comes with consistency and precision.
Predictable Precision
The first FDA-cleared, automated surgical robot for the surgical treatment of lower urinary tract symptoms due to BPH, offering the peace of mind that comes with consistency and precision.
Better Science, Proven Data
Doubling down on scientific rigor, PROCEPT BioRobotics’ powerful WATER Study was randomized against the surgical gold-standard TURP.
Better Science, Proven Data
Doubling down on scientific rigor, PROCEPT BioRobotics’ powerful WATER Study was randomized against the surgical gold-standard TURP.
Better Science, Proven Data
Doubling down on scientific rigor, PROCEPT BioRobotics’ powerful WATER Study was randomized against the surgical gold-standard TURP.
Discover our most recent achievements, where to find us, and what industry publications have to say about us.
Press Releases
- May 3, 2019 AUA Amends Clinical Practice Guidelines to Include PROCEPT BioRobotics’ Aquablation Therapy as a Standard of Care Option for the Treatment of Enlarged Prostate
- May 1, 2019 Multiple Presentations to Highlight Longer-Term Clinical Data and Real-World Experience in Support of Aquablation Therapy at AUA 2019
- May 15, 2018 WATER Study One-Year Data and WATER II Primary Endpoint Data for PROCEPT BioRobotics’ Aquablation® Therapy to be Presented at AUA 2018
Events
Discover our most recent achievements, where to find us, and what industry publications have to say about us.
Press Releases
- May 3, 2019 AUA Amends Clinical Practice Guidelines to Include PROCEPT BioRobotics’ Aquablation Therapy as a Standard of Care Option for the Treatment of Enlarged Prostate
- May 1, 2019 Multiple Presentations to Highlight Longer-Term Clinical Data and Real-World Experience in Support of Aquablation Therapy at AUA 2019
- May 15, 2018 WATER Study One-Year Data and WATER II Primary Endpoint Data for PROCEPT BioRobotics’ Aquablation® Therapy to be Presented at AUA 2018
Events
Aquablation Therapy Resources
Aquablation Therapy
